投稿一覧に戻る グライコミメティクス【GLYC】の掲示板 6 far***** 5月6日 22:37 Study of uproleselan combined with chemotherapy did not meet its primary endpoint of overall survival in the intent to treat population Participants in the uproleselan arm had a median overall survival of 13 months vs. 12.3 months in the placebo arm. 返信する そう思う0 そう思わない0 開く お気に入りユーザーに登録する 無視ユーザーに登録する 違反報告する 証券取引等監視委員会に情報提供する ツイート 投稿一覧に戻る
Study of uproleselan combined with chemotherapy did not meet its primary endpoint of overall survival in the intent to treat population
Participants in the uproleselan arm had a median overall survival of 13 months vs. 12.3 months in the placebo arm.